178 related articles for article (PubMed ID: 4569916)
1. Intracellular fate of Cryptococcus neoformans.
Tacker JR; Farhi F; Bulmer GS
Infect Immun; 1972 Aug; 6(2):162-7. PubMed ID: 4569916
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcus neoformans. 3. Inhibition of phagocytosis.
Bulmer GS; Sans MD
J Bacteriol; 1968 Jan; 95(1):5-8. PubMed ID: 4866104
[TBL] [Abstract][Full Text] [Related]
3. Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.
Kozel TR
Infect Immun; 1977 Apr; 16(1):99-106. PubMed ID: 326680
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.
Kozel TR
Infect Immun; 1983 Mar; 39(3):1214-9. PubMed ID: 6341232
[TBL] [Abstract][Full Text] [Related]
5. Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
Kozel TR; Hermerath CA
Infect Immun; 1984 Mar; 43(3):879-86. PubMed ID: 6365785
[TBL] [Abstract][Full Text] [Related]
6. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.
Ikeda R; Shinoda T; Kagaya K; Fukazawa Y
Microbiol Immunol; 1984; 28(1):51-61. PubMed ID: 6374392
[TBL] [Abstract][Full Text] [Related]
7. Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide.
Kozel TR; Reiss E; Cherniak R
Infect Immun; 1980 Aug; 29(2):295-300. PubMed ID: 7011970
[TBL] [Abstract][Full Text] [Related]
8. Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.
McGaw TG; Kozel TR
Infect Immun; 1979 Jul; 25(1):262-7. PubMed ID: 383615
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
Bulmer GS; Sans MD
J Bacteriol; 1967 Nov; 94(5):1480-3. PubMed ID: 4862192
[TBL] [Abstract][Full Text] [Related]
10. Phagocytosis of Cryptococcus neoformans by alveolar macrophages.
Bulmer GS; Tacker JR
Infect Immun; 1975 Jan; 11(1):73-9. PubMed ID: 1090528
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.
Kozel TR; Mastroianni RP
Infect Immun; 1976 Jul; 14(1):62-7. PubMed ID: 780279
[TBL] [Abstract][Full Text] [Related]
12. Role of the capsule in phagocytosis of Cryptococcus neoformans.
Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
Rev Infect Dis; 1988; 10 Suppl 2():S436-9. PubMed ID: 3055212
[TBL] [Abstract][Full Text] [Related]
13. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum.
Bolaños B; Mitchell TG
J Leukoc Biol; 1989 Dec; 46(6):521-8. PubMed ID: 2681492
[TBL] [Abstract][Full Text] [Related]
14. Opsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomannan antibodies.
Zhong Z; Pirofski LA
Infect Immun; 1996 Sep; 64(9):3446-50. PubMed ID: 8751883
[TBL] [Abstract][Full Text] [Related]
15. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils.
Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A
Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070
[TBL] [Abstract][Full Text] [Related]
16. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
Kozel TR; Follette JL
Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
[TBL] [Abstract][Full Text] [Related]
17. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.
Small JM; Mitchell TG
Infect Immun; 1989 Dec; 57(12):3751-6. PubMed ID: 2680980
[TBL] [Abstract][Full Text] [Related]
18. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
Kozel TR; Gotschlich EC
J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244
[TBL] [Abstract][Full Text] [Related]
19. Capsular specific IgM enhances complement-mediated phagocytosis and killing of Cryptococcus neoformans by methamphetamine-treated J774.16 macrophage-like cells.
Aslanyan L; Ekhar VV; DeLeon-Rodriguez CM; Martinez LR
Int Immunopharmacol; 2017 Aug; 49():77-84. PubMed ID: 28551495
[TBL] [Abstract][Full Text] [Related]
20. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.
Kozel TR; Highison B; Stratton CJ
Infect Immun; 1984 Feb; 43(2):574-9. PubMed ID: 6363293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
